West Pharmaceutical forecasts 2025 results below expectations, shares drop
Feb 13 (Reuters) - West Pharmaceutical Services (WST.N), opens new tab forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong dollar and as the medical equipment maker's clients reduce inventory levels, sending its shares down 18% premarket.
It forecast 2025 revenue of between $2.88 billion and $2.91 billion, with the midpoint below analysts' estimates of $3.04 billion, according to data compiled by LSEG.
The company expects 2025 adjusted earnings per share of between $6 and $6.20, compared with estimates of $7.44.
"The impact of destocking continues to moderate," CEO Eric Green said in a statement.
West Pharma's revenues and order books have been under pressure from biotech clients depleting inventories they had built up during pandemic-era supply chain disruptions.
However, the company's fourth-quarter profit and revenue both came in above expectations, due to rising demand in its business that makes cartridges and syringes used to manufacture injectable therapies.
Revenue in the proprietary products unit came in at $613.9 million, above analysts' average estimates of $597.8 million. The segment makes up more than half of the company's total revenues.
The company reported total revenue of $748.8 million for the fourth quarter ended December 31, compared with estimates of $740.5 million
On an adjusted basis, the company posted a profit of $1.82 per share, compared with estimates of $1.72.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
an hour ago
- Reuters
Dollar and other safe havens rise as Israel strikes Iran
June 13 (Reuters) - The U.S. dollar rallied alongside the safe-haven Japanese yen and Swiss franc, with currency markets abruptly reversing direction on news Israel had launched strikes on Iran. Israel has begun carrying out strikes on Iran, two U.S. officials told Reuters, adding that there was no U.S. assistance or involvement in the operation. Another report suggested that explosions were heard northeast of Iran's capital Tehran. An index that measures the dollar against six other currencies gained 0.4%, and was last at 98.07, in early Asia trading. Against the yen, the dollar slipped 0.35% to 143 per dollar , while the Swiss franc tumbled 0.39% to 0.807 per dollar. Risk-sensitive Asian currencies such as the Aussie dollar and the New Zealand dollar weakened 0.9% each. Earlier in the week, the dollar index hit multi-year lows as investors were not impressed by a U.S.-China trade truce, while cooler-than-expected inflation data fuelled expectations of more aggressive interest rate cuts by the Federal Reserve. The dollar is on track for weekly declines against the yen, the Swiss franc and the euro. Crude prices , jumped more than $4 on the news as investors priced in potential supply disruptions from the oil-rich region, while gold prices climbed 0.8% to their strongest since early May.
Reuters
2 hours ago
- Reuters
Oil prices jump more than $4 after Israel strikes Iran
June 13 (Reuters) - Oil prices jumped more than $4 a barrel on Friday after Israel said it struck Iran, raising concerns of escalating tensions in the Middle East that may affect oil supplies. Brent crude futures were up $4.02, or 5.8%, at $73.38 a barrel. U.S. West Texas Intermediate crude was up $4.35, or 6.39%, at $72.39 a barrel at 0029 GMT.
Reuters
4 hours ago
- Reuters
Four must-see charts following USDA's latest data drop: Braun
NAPERVILLE, Illinois, June 12 (Reuters) - Another month, another fresh set of numbers. While the U.S. Department of Agriculture's monthly supply and demand report on Thursday did not shake things up too much versus trade expectations, there were some adjustments – and lack thereof - that are certainly worth a closer look. USDA raised 2024-25 U.S. corn exports on Thursday, perhaps by a bit more than expected. The new 2.65 billion-bushel target would be the second-best on record. But there is an argument for an even higher number. As of June 5, total U.S. corn sales for export in 2024-25 covered 98% of USDA's forecast, which is about as good as it gets. In the previous 18 years, there were eight instances where sales coverage by this date exceeded 95%. In seven of those eight years, final exports were higher than what USDA had estimated in June. The record volume year of 2020-21 is the one outlier, which could raise concerns about additional increases for 2024-25 given how strong the expectations already are. But there is no evidence that this is necessarily a limiting factor. Right before the 2025-26 U.S. wheat marketing year began on June 1, cumulative pre-season export sales had reached a 12-year high. But as of June 5, the 5.9 million-metric-ton total was only an eight-year high for the date. The shift can be explained. Large, unshipped balances at the end of a marketing year sometimes get rolled over to the new one. Still, the 2025-26 progress is impressive. Total sales now cover 26.3% of USDA's freshly increased, full-year export forecast of 22.45 million tons. That portion is a 12-year high and compares with a five-year average of 21.9% by this same date. Although U.S. wheat exports are expected to hit five-year highs, they may still lack on the world stage. The United States is seen accounting for 10.5% of global shipments in 2025-26, down slightly from the prior year and the third-lowest share in decades. Forecast discrepancies between USDA and its Brazilian counterpart Conab have been in focus over the past year or so, but those deviations took a new turn this month. Conab on Thursday increased its 2024-25 Brazilian soy crop estimate to 169.6 million tons from 168.3 million last month. For an unprecedented 13th consecutive month, USDA left its projection unchanged at 169 million. That marks the first time in eight years that USDA's estimate is lighter than Conab's. However, the two numbers are very close, as are the two agencies' figures for Brazil's 2024-25 soybean ending stocks. This means they may have found synchrony on both supply and demand assumptions, though the agencies may have to revisit pending the outcome of Brazil's in-progress soy export program. On the corn side, Conab increased its 2024-25 Brazilian harvest outlook while USDA's was unchanged. USDA's projection sits 1.4% above Conab's, the smallest discrepancy in four years. Global corn stocks and stocks-to-use are still expected to hit respective 12- and 13-year lows in 2025-26, though the numbers tightened further on Thursday with a reduction in old-crop stocks. The 2025-26 stocks-to-use figure of 18.7% is down from 19.7% a year earlier and 22.3% in 2023-24. That is above the 12% to 15% levels seen between 2010 and 2013, a period of high grain prices and ongoing supply struggles. But it still suggests there is not a ton of play in the global corn numbers, and major exporters' crops must meet expectations. That includes a record U.S. crop target, and things are off to a decent start. That recently sent new-crop CBOT corn futures to six-month lows, and prices are at five-year lows for the date. A big test is coming on June 30. Not only will USDA reveal more information about current U.S. stockpiles, but volume expectations for the 2025-26 U.S. corn harvest could be completely reset if the acreage survey offers a surprise. Such a surprise would not at all be … surprising. Corn acreage has landed outside the range of trade predictions in four of the past six Junes, meaning this month could conclude with some volatile trade. Karen Braun is a market analyst for Reuters. Views expressed above are her own. Enjoying this column? Check out Reuters Open Interest (ROI), opens new tab, your essential new source for global financial commentary. ROI delivers thought-provoking, data-driven analysis of everything from swap rates to soybeans. Markets are moving faster than ever. ROI, opens new tab can help you keep up. Follow ROI on LinkedIn, opens new tab and X., opens new tab
